Amkay Products Ltd
₹
- close price
About
Incorporated in 2007, Amkay Products Ltd manufactures personalized healthcare products[1]
Key Points
- Market Cap ₹ Cr.
- Current Price ₹
- High / Low ₹ /
- Stock P/E
- Book Value ₹
- Dividend Yield %
- ROCE %
- ROE %
- Face Value ₹
Pros
Cons
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Loading peers table ...
Quarterly Results
Figures in Rs. Crores
| Operating Profit |
| OPM % |
| Interest |
| Depreciation |
| Profit before tax |
| Tax % |
| EPS in Rs |
| Raw PDF |
Profit & Loss
Figures in Rs. Crores
| Operating Profit |
| OPM % |
| Interest |
| Depreciation |
| Profit before tax |
| Tax % |
| EPS in Rs |
| Dividend Payout % |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| TTM: | % |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| TTM: | % |
| Stock Price CAGR | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| 1 Year: | % |
| Return on Equity | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| Last Year: | % |
Balance Sheet
Figures in Rs. Crores
| Equity Capital |
| Reserves |
| Total Liabilities |
| CWIP |
| Investments |
| Total Assets |
Cash Flows
Figures in Rs. Crores
| Net Cash Flow |
| Free Cash Flow |
| CFO/OP |
Ratios
Figures in Rs. Crores
| Debtor Days |
| Inventory Days |
| Days Payable |
| Cash Conversion Cycle |
| Working Capital Days |
| ROCE % |
Insights
In beta| Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|
| Foreign Exchange Earnings INR Lakhs ・Standalone data |
|
||
| Number of Manufacturing Units Count ・Standalone data |
|||
| Average Salary Increase (Non-managerial) % ・Standalone data |
|||
| Median Remuneration Increase % ・Standalone data |
|||
| Number of Permanent Employees Count ・Standalone data |
|||
Requires Premium
Requires Premium
Extracted by Screener AI
Documents
Announcements
-
Format of the Annual Disclosure to be made by an entity identified as a LC - Annexure B2
27 Apr - Amkay Products confirms it is not a Large Corporate under SEBI debt-fundraising norms.
-
Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A
27 Apr - Amkay Products confirms it is not a Large Corporate under SEBI debt funding framework.
- Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 6 Apr
-
Closure of Trading Window
25 Mar - Trading window closed April 1, 2026 until 48 hours after FY2026 results.
-
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
7 Jan - Certificate under Reg 74(5): all shares dematerialised; no rematerialisation requests for quarter ended 31 Dec 2025.
Business Overview:[1][2]
APL manufactures medical devices, disposables and other Healthcare Products like Face Mask, Alcohol Swabs, Lancet Needles, Nebulizer, Pulse Oximeter, Surgeon cap etc. These are used by healthcare centres, hospitals, nursing homes etc., under the brand name Amkay.
APL is the largest manufacturer of Blood Lancet Needles - Steel/Plastic in India. They have 50+ SKUs and 1000+ Distributors